|
|
Volumn 59, Issue 6, 1999, Pages 369-375
|
|
Acceptability of once-a-month injectable contraceptives cyclofem® and mesigyna®: Focus group discussion
|
|
Author keywords
Acceptability; Cyclofem; Focus group; Mesigyna
|
|
Indexed keywords
CONTRACEPTIVE AGENT;
ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE;
ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE;
INJECTABLE CONTRACEPTIVE AGENT;
ADULT;
ARTICLE;
ATTITUDE;
BREAKTHROUGH BLEEDING;
CLINICAL TRIAL;
CONTRACEPTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EGYPT;
FEMALE;
FERTILITY;
HAIR LOSS;
HEADACHE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
VERTIGO;
WEIGHT GAIN;
AFRICA;
ARAB COUNTRIES;
CONTRACEPTION;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVE AGENTS, PROGESTIN;
CONTRACEPTIVE METHODS;
CONTRACEPTIVE USAGE;
DATA COLLECTION;
DEVELOPING COUNTRIES;
EGYPT;
FAMILY PLANNING;
FOCUS GROUPS;
INJECTABLES;
MEDITERRANEAN COUNTRIES;
METHOD ACCEPTABILITY--WOMEN;
NORTHERN AFRICA;
RESEARCH METHODOLOGY;
RESEARCH REPORT;
WOMEN;
ADULT;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVES, ORAL, COMBINED;
COUNSELING;
DRUG COMBINATIONS;
EGYPT;
ESTRADIOL;
FEMALE;
FOCUS GROUPS;
HUMANS;
ISLAM;
MEDROXYPROGESTERONE 17-ACETATE;
NORETHINDRONE;
PATIENT SATISFACTION;
SOCIAL SUPPORT;
|
|
EID: 0032821612
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-7824(99)00050-5 Document Type: Article |
|
Times cited : (2)
|
|
References (8)
|
